InvestorsHub Logo
Followers 5
Posts 358
Boards Moderated 0
Alias Born 02/06/2006

Re: Cody4 post# 152379

Thursday, 03/11/2021 9:52:40 AM

Thursday, March 11, 2021 9:52:40 AM

Post# of 233066
In our CD10 COVID mild-to-moderate trial with leronlimab, we noted a reduction in adverse events or symptoms including fatigue, diarrhea, chest pain, fatigue, muscle weakness, and anxiety in treated vs. placebo groups.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News